Bullous pemphigoid (BP) is the most common autoimmune blistering disease in the West. Incidence figures are not available for most parts of the world but BP appears to be rarer in the Far East. Bullous pemphigoid is usually a disease of the elderly but it can also affect younger people and children. Both sexes are similarly affected.

The global Bullous Pemphigoid Therapies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Bullous Pemphigoid Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bullous Pemphigoid Therapies.

Report Scope

The Bullous Pemphigoid Therapies market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bullous Pemphigoid Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Bullous Pemphigoid Therapies manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Bullous Pemphigoid Therapies Market Report

Report Metric	Details
Report Name	Bullous Pemphigoid Therapies Market
CAGR	5%
Segment by Type	Steroid Creams Immune Suppressants Antibiotics
Segment by Application	Initial Phase Active Treatment Phase Reducing Phase Maintenance Phase
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Regeneron Pharmaceuticals, Sanofi, Pfizer, SUANFARMA, Tecoland Corporation, Century Pharmaceuticals, Akari Therapeutics, Immune Pharmaceuticals, Innate Pharma, AstraZeneca, Grifols, Aptalis, Medicis Pharmaceutical Corporation, Shaanxi Xiyue Pharmaceutical, Kunming Zhenhua Pharmaceutical Factory, Qinghai Pharmaceutical Factory
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bullous Pemphigoid Therapies manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bullous Pemphigoid Therapies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Bullous Pemphigoid Therapies Market report?

Ans: The main players in the Bullous Pemphigoid Therapies Market are Regeneron Pharmaceuticals, Sanofi, Pfizer, SUANFARMA, Tecoland Corporation, Century Pharmaceuticals, Akari Therapeutics, Immune Pharmaceuticals, Innate Pharma, AstraZeneca, Grifols, Aptalis, Medicis Pharmaceutical Corporation, Shaanxi Xiyue Pharmaceutical, Kunming Zhenhua Pharmaceutical Factory, Qinghai Pharmaceutical Factory

What are the Application segmentation covered in the Bullous Pemphigoid Therapies Market report?

Ans: The Applications covered in the Bullous Pemphigoid Therapies Market report are Initial Phase, Active Treatment Phase, Reducing Phase, Maintenance Phase

What are the Type segmentation covered in the Bullous Pemphigoid Therapies Market report?

Ans: The Types covered in the Bullous Pemphigoid Therapies Market report are Steroid Creams, Immune Suppressants, Antibiotics

1 Bullous Pemphigoid Therapies Market Overview

1.1 Product Overview and Scope of Bullous Pemphigoid Therapies

1.2 Bullous Pemphigoid Therapies Segment by Type

1.2.1 Global Bullous Pemphigoid Therapies Market Value Comparison by Type (2024-2030)

1.2.2 Steroid Creams

1.2.3 Immune Suppressants

1.2.4 Antibiotics

1.3 Bullous Pemphigoid Therapies Segment by Application

1.3.1 Global Bullous Pemphigoid Therapies Market Value by Application: (2024-2030)

1.3.2 Initial Phase

1.3.3 Active Treatment Phase

1.3.4 Reducing Phase

1.3.5 Maintenance Phase

1.4 Global Bullous Pemphigoid Therapies Market Size Estimates and Forecasts

1.4.1 Global Bullous Pemphigoid Therapies Revenue 2019-2030

1.4.2 Global Bullous Pemphigoid Therapies Sales 2019-2030

1.4.3 Global Bullous Pemphigoid Therapies Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Bullous Pemphigoid Therapies Market Competition by Manufacturers

2.1 Global Bullous Pemphigoid Therapies Sales Market Share by Manufacturers (2019-2024)

2.2 Global Bullous Pemphigoid Therapies Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Bullous Pemphigoid Therapies Average Price by Manufacturers (2019-2024)

2.4 Global Bullous Pemphigoid Therapies Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Bullous Pemphigoid Therapies, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Bullous Pemphigoid Therapies, Product Type & Application

2.7 Bullous Pemphigoid Therapies Market Competitive Situation and Trends

2.7.1 Bullous Pemphigoid Therapies Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Bullous Pemphigoid Therapies Players Market Share by Revenue

2.7.3 Global Bullous Pemphigoid Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Bullous Pemphigoid Therapies Retrospective Market Scenario by Region

3.1 Global Bullous Pemphigoid Therapies Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Bullous Pemphigoid Therapies Global Bullous Pemphigoid Therapies Sales by Region: 2019-2030

3.2.1 Global Bullous Pemphigoid Therapies Sales by Region: 2019-2024

3.2.2 Global Bullous Pemphigoid Therapies Sales by Region: 2025-2030

3.3 Global Bullous Pemphigoid Therapies Global Bullous Pemphigoid Therapies Revenue by Region: 2019-2030

3.3.1 Global Bullous Pemphigoid Therapies Revenue by Region: 2019-2024

3.3.2 Global Bullous Pemphigoid Therapies Revenue by Region: 2025-2030

3.4 North America Bullous Pemphigoid Therapies Market Facts & Figures by Country

3.4.1 North America Bullous Pemphigoid Therapies Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Bullous Pemphigoid Therapies Sales by Country (2019-2030)

3.4.3 North America Bullous Pemphigoid Therapies Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Bullous Pemphigoid Therapies Market Facts & Figures by Country

3.5.1 Europe Bullous Pemphigoid Therapies Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Bullous Pemphigoid Therapies Sales by Country (2019-2030)

3.5.3 Europe Bullous Pemphigoid Therapies Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Bullous Pemphigoid Therapies Market Facts & Figures by Country

3.6.1 Asia Pacific Bullous Pemphigoid Therapies Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Bullous Pemphigoid Therapies Sales by Country (2019-2030)

3.6.3 Asia Pacific Bullous Pemphigoid Therapies Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Bullous Pemphigoid Therapies Market Facts & Figures by Country

3.7.1 Latin America Bullous Pemphigoid Therapies Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Bullous Pemphigoid Therapies Sales by Country (2019-2030)

3.7.3 Latin America Bullous Pemphigoid Therapies Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Bullous Pemphigoid Therapies Market Facts & Figures by Country

3.8.1 Middle East and Africa Bullous Pemphigoid Therapies Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Bullous Pemphigoid Therapies Sales by Country (2019-2030)

3.8.3 Middle East and Africa Bullous Pemphigoid Therapies Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Bullous Pemphigoid Therapies Sales by Type (2019-2030)

4.1.1 Global Bullous Pemphigoid Therapies Sales by Type (2019-2024)

4.1.2 Global Bullous Pemphigoid Therapies Sales by Type (2025-2030)

4.1.3 Global Bullous Pemphigoid Therapies Sales Market Share by Type (2019-2030)

4.2 Global Bullous Pemphigoid Therapies Revenue by Type (2019-2030)

4.2.1 Global Bullous Pemphigoid Therapies Revenue by Type (2019-2024)

4.2.2 Global Bullous Pemphigoid Therapies Revenue by Type (2025-2030)

4.2.3 Global Bullous Pemphigoid Therapies Revenue Market Share by Type (2019-2030)

4.3 Global Bullous Pemphigoid Therapies Price by Type (2019-2030)

5 Segment by Application

5.1 Global Bullous Pemphigoid Therapies Sales by Application (2019-2030)

5.1.1 Global Bullous Pemphigoid Therapies Sales by Application (2019-2024)

5.1.2 Global Bullous Pemphigoid Therapies Sales by Application (2025-2030)

5.1.3 Global Bullous Pemphigoid Therapies Sales Market Share by Application (2019-2030)

5.2 Global Bullous Pemphigoid Therapies Revenue by Application (2019-2030)

5.2.1 Global Bullous Pemphigoid Therapies Revenue by Application (2019-2024)

5.2.2 Global Bullous Pemphigoid Therapies Revenue by Application (2025-2030)

5.2.3 Global Bullous Pemphigoid Therapies Revenue Market Share by Application (2019-2030)

5.3 Global Bullous Pemphigoid Therapies Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Regeneron Pharmaceuticals

6.1.1 Regeneron Pharmaceuticals Corporation Information

6.1.2 Regeneron Pharmaceuticals Description and Business Overview

6.1.3 Regeneron Pharmaceuticals Bullous Pemphigoid Therapies Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Regeneron Pharmaceuticals Bullous Pemphigoid Therapies Product Portfolio

6.1.5 Regeneron Pharmaceuticals Recent Developments/Updates

6.2 Sanofi

6.2.1 Sanofi Corporation Information

6.2.2 Sanofi Description and Business Overview

6.2.3 Sanofi Bullous Pemphigoid Therapies Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Sanofi Bullous Pemphigoid Therapies Product Portfolio

6.2.5 Sanofi Recent Developments/Updates

6.3 Pfizer

6.3.1 Pfizer Corporation Information

6.3.2 Pfizer Description and Business Overview

6.3.3 Pfizer Bullous Pemphigoid Therapies Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Pfizer Bullous Pemphigoid Therapies Product Portfolio

6.3.5 Pfizer Recent Developments/Updates

6.4 SUANFARMA

6.4.1 SUANFARMA Corporation Information

6.4.2 SUANFARMA Description and Business Overview

6.4.3 SUANFARMA Bullous Pemphigoid Therapies Sales, Revenue and Gross Margin (2019-2024)

6.4.4 SUANFARMA Bullous Pemphigoid Therapies Product Portfolio

6.4.5 SUANFARMA Recent Developments/Updates

6.5 Tecoland Corporation

6.5.1 Tecoland Corporation Corporation Information

6.5.2 Tecoland Corporation Description and Business Overview

6.5.3 Tecoland Corporation Bullous Pemphigoid Therapies Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Tecoland Corporation Bullous Pemphigoid Therapies Product Portfolio

6.5.5 Tecoland Corporation Recent Developments/Updates

6.6 Century Pharmaceuticals

6.6.1 Century Pharmaceuticals Corporation Information

6.6.2 Century Pharmaceuticals Description and Business Overview

6.6.3 Century Pharmaceuticals Bullous Pemphigoid Therapies Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Century Pharmaceuticals Bullous Pemphigoid Therapies Product Portfolio

6.6.5 Century Pharmaceuticals Recent Developments/Updates

6.7 Akari Therapeutics

6.6.1 Akari Therapeutics Corporation Information

6.6.2 Akari Therapeutics Description and Business Overview

6.6.3 Akari Therapeutics Bullous Pemphigoid Therapies Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Akari Therapeutics Bullous Pemphigoid Therapies Product Portfolio

6.7.5 Akari Therapeutics Recent Developments/Updates

6.8 Immune Pharmaceuticals

6.8.1 Immune Pharmaceuticals Corporation Information

6.8.2 Immune Pharmaceuticals Description and Business Overview

6.8.3 Immune Pharmaceuticals Bullous Pemphigoid Therapies Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Immune Pharmaceuticals Bullous Pemphigoid Therapies Product Portfolio

6.8.5 Immune Pharmaceuticals Recent Developments/Updates

6.9 Innate Pharma

6.9.1 Innate Pharma Corporation Information

6.9.2 Innate Pharma Description and Business Overview

6.9.3 Innate Pharma Bullous Pemphigoid Therapies Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Innate Pharma Bullous Pemphigoid Therapies Product Portfolio

6.9.5 Innate Pharma Recent Developments/Updates

6.10 AstraZeneca

6.10.1 AstraZeneca Corporation Information

6.10.2 AstraZeneca Description and Business Overview

6.10.3 AstraZeneca Bullous Pemphigoid Therapies Sales, Revenue and Gross Margin (2019-2024)

6.10.4 AstraZeneca Bullous Pemphigoid Therapies Product Portfolio

6.10.5 AstraZeneca Recent Developments/Updates

6.11 Grifols

6.11.1 Grifols Corporation Information

6.11.2 Grifols Bullous Pemphigoid Therapies Description and Business Overview

6.11.3 Grifols Bullous Pemphigoid Therapies Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Grifols Bullous Pemphigoid Therapies Product Portfolio

6.11.5 Grifols Recent Developments/Updates

6.12 Aptalis

6.12.1 Aptalis Corporation Information

6.12.2 Aptalis Bullous Pemphigoid Therapies Description and Business Overview

6.12.3 Aptalis Bullous Pemphigoid Therapies Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Aptalis Bullous Pemphigoid Therapies Product Portfolio

6.12.5 Aptalis Recent Developments/Updates

6.13 Medicis Pharmaceutical Corporation

6.13.1 Medicis Pharmaceutical Corporation Corporation Information

6.13.2 Medicis Pharmaceutical Corporation Bullous Pemphigoid Therapies Description and Business Overview

6.13.3 Medicis Pharmaceutical Corporation Bullous Pemphigoid Therapies Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Medicis Pharmaceutical Corporation Bullous Pemphigoid Therapies Product Portfolio

6.13.5 Medicis Pharmaceutical Corporation Recent Developments/Updates

6.14 Shaanxi Xiyue Pharmaceutical

6.14.1 Shaanxi Xiyue Pharmaceutical Corporation Information

6.14.2 Shaanxi Xiyue Pharmaceutical Bullous Pemphigoid Therapies Description and Business Overview

6.14.3 Shaanxi Xiyue Pharmaceutical Bullous Pemphigoid Therapies Sales, Revenue and Gross Margin (2019-2024)

6.14.4 Shaanxi Xiyue Pharmaceutical Bullous Pemphigoid Therapies Product Portfolio

6.14.5 Shaanxi Xiyue Pharmaceutical Recent Developments/Updates

6.15 Kunming Zhenhua Pharmaceutical Factory

6.15.1 Kunming Zhenhua Pharmaceutical Factory Corporation Information

6.15.2 Kunming Zhenhua Pharmaceutical Factory Bullous Pemphigoid Therapies Description and Business Overview

6.15.3 Kunming Zhenhua Pharmaceutical Factory Bullous Pemphigoid Therapies Sales, Revenue and Gross Margin (2019-2024)

6.15.4 Kunming Zhenhua Pharmaceutical Factory Bullous Pemphigoid Therapies Product Portfolio

6.15.5 Kunming Zhenhua Pharmaceutical Factory Recent Developments/Updates

6.16 Qinghai Pharmaceutical Factory

6.16.1 Qinghai Pharmaceutical Factory Corporation Information

6.16.2 Qinghai Pharmaceutical Factory Bullous Pemphigoid Therapies Description and Business Overview

6.16.3 Qinghai Pharmaceutical Factory Bullous Pemphigoid Therapies Sales, Revenue and Gross Margin (2019-2024)

6.16.4 Qinghai Pharmaceutical Factory Bullous Pemphigoid Therapies Product Portfolio

6.16.5 Qinghai Pharmaceutical Factory Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Bullous Pemphigoid Therapies Industry Chain Analysis

7.2 Bullous Pemphigoid Therapies Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Bullous Pemphigoid Therapies Production Mode & Process

7.4 Bullous Pemphigoid Therapies Sales and Marketing

7.4.1 Bullous Pemphigoid Therapies Sales Channels

7.4.2 Bullous Pemphigoid Therapies Distributors

7.5 Bullous Pemphigoid Therapies Customers

8 Bullous Pemphigoid Therapies Market Dynamics

8.1 Bullous Pemphigoid Therapies Industry Trends

8.2 Bullous Pemphigoid Therapies Market Drivers

8.3 Bullous Pemphigoid Therapies Market Challenges

8.4 Bullous Pemphigoid Therapies Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Regeneron Pharmaceuticals

Century Pharmaceuticals

Akari Therapeutics

Immune Pharmaceuticals

Medicis Pharmaceutical Corporation

Shaanxi Xiyue Pharmaceutical

Kunming Zhenhua Pharmaceutical Factory

Qinghai pharmaceutical factory

List of Tables

Table 1. Global Bullous Pemphigoid Therapies Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Bullous Pemphigoid Therapies Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Bullous Pemphigoid Therapies Market Competitive Situation by Manufacturers in 2023

Table 4. Global Bullous Pemphigoid Therapies Sales (Units) of Key Manufacturers (2019-2024)

Table 5. Global Bullous Pemphigoid Therapies Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Bullous Pemphigoid Therapies Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Bullous Pemphigoid Therapies Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Bullous Pemphigoid Therapies Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Bullous Pemphigoid Therapies, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Bullous Pemphigoid Therapies, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Bullous Pemphigoid Therapies, Product Type & Application

Table 12. Global Key Manufacturers of Bullous Pemphigoid Therapies, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Bullous Pemphigoid Therapies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bullous Pemphigoid Therapies as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Bullous Pemphigoid Therapies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Bullous Pemphigoid Therapies Sales by Region (2019-2024) & (Units)

Table 18. Global Bullous Pemphigoid Therapies Sales Market Share by Region (2019-2024)

Table 19. Global Bullous Pemphigoid Therapies Sales by Region (2025-2030) & (Units)

Table 20. Global Bullous Pemphigoid Therapies Sales Market Share by Region (2025-2030)

Table 21. Global Bullous Pemphigoid Therapies Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Bullous Pemphigoid Therapies Revenue Market Share by Region (2019-2024)

Table 23. Global Bullous Pemphigoid Therapies Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Bullous Pemphigoid Therapies Revenue Market Share by Region (2025-2030)

Table 25. North America Bullous Pemphigoid Therapies Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Bullous Pemphigoid Therapies Sales by Country (2019-2024) & (Units)

Table 27. North America Bullous Pemphigoid Therapies Sales by Country (2025-2030) & (Units)

Table 28. North America Bullous Pemphigoid Therapies Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Bullous Pemphigoid Therapies Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Bullous Pemphigoid Therapies Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Bullous Pemphigoid Therapies Sales by Country (2019-2024) & (Units)

Table 32. Europe Bullous Pemphigoid Therapies Sales by Country (2025-2030) & (Units)

Table 33. Europe Bullous Pemphigoid Therapies Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Bullous Pemphigoid Therapies Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Bullous Pemphigoid Therapies Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Bullous Pemphigoid Therapies Sales by Region (2019-2024) & (Units)

Table 37. Asia Pacific Bullous Pemphigoid Therapies Sales by Region (2025-2030) & (Units)

Table 38. Asia Pacific Bullous Pemphigoid Therapies Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Bullous Pemphigoid Therapies Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Bullous Pemphigoid Therapies Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Bullous Pemphigoid Therapies Sales by Country (2019-2024) & (Units)

Table 42. Latin America Bullous Pemphigoid Therapies Sales by Country (2025-2030) & (Units)

Table 43. Latin America Bullous Pemphigoid Therapies Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Bullous Pemphigoid Therapies Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Bullous Pemphigoid Therapies Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Bullous Pemphigoid Therapies Sales by Country (2019-2024) & (Units)

Table 47. Middle East & Africa Bullous Pemphigoid Therapies Sales by Country (2025-2030) & (Units)

Table 48. Middle East & Africa Bullous Pemphigoid Therapies Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Bullous Pemphigoid Therapies Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Bullous Pemphigoid Therapies Sales (Units) by Type (2019-2024)

Table 51. Global Bullous Pemphigoid Therapies Sales (Units) by Type (2025-2030)

Table 52. Global Bullous Pemphigoid Therapies Sales Market Share by Type (2019-2024)

Table 53. Global Bullous Pemphigoid Therapies Sales Market Share by Type (2025-2030)

Table 54. Global Bullous Pemphigoid Therapies Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Bullous Pemphigoid Therapies Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Bullous Pemphigoid Therapies Revenue Market Share by Type (2019-2024)

Table 57. Global Bullous Pemphigoid Therapies Revenue Market Share by Type (2025-2030)

Table 58. Global Bullous Pemphigoid Therapies Price (US$/Unit) by Type (2019-2024)

Table 59. Global Bullous Pemphigoid Therapies Price (US$/Unit) by Type (2025-2030)

Table 60. Global Bullous Pemphigoid Therapies Sales (Units) by Application (2019-2024)

Table 61. Global Bullous Pemphigoid Therapies Sales (Units) by Application (2025-2030)

Table 62. Global Bullous Pemphigoid Therapies Sales Market Share by Application (2019-2024)

Table 63. Global Bullous Pemphigoid Therapies Sales Market Share by Application (2025-2030)

Table 64. Global Bullous Pemphigoid Therapies Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Bullous Pemphigoid Therapies Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Bullous Pemphigoid Therapies Revenue Market Share by Application (2019-2024)

Table 67. Global Bullous Pemphigoid Therapies Revenue Market Share by Application (2025-2030)

Table 68. Global Bullous Pemphigoid Therapies Price (US$/Unit) by Application (2019-2024)

Table 69. Global Bullous Pemphigoid Therapies Price (US$/Unit) by Application (2025-2030)

Table 70. Regeneron Pharmaceuticals Corporation Information

Table 71. Regeneron Pharmaceuticals Description and Business Overview

Table 72. Regeneron Pharmaceuticals Bullous Pemphigoid Therapies Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Regeneron Pharmaceuticals Bullous Pemphigoid Therapies Product

Table 74. Regeneron Pharmaceuticals Recent Developments/Updates

Table 75. Sanofi Corporation Information

Table 76. Sanofi Description and Business Overview

Table 77. Sanofi Bullous Pemphigoid Therapies Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Sanofi Bullous Pemphigoid Therapies Product

Table 79. Sanofi Recent Developments/Updates

Table 80. Pfizer Corporation Information

Table 81. Pfizer Description and Business Overview

Table 82. Pfizer Bullous Pemphigoid Therapies Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Pfizer Bullous Pemphigoid Therapies Product

Table 84. Pfizer Recent Developments/Updates

Table 85. SUANFARMA Corporation Information

Table 86. SUANFARMA Description and Business Overview

Table 87. SUANFARMA Bullous Pemphigoid Therapies Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. SUANFARMA Bullous Pemphigoid Therapies Product

Table 89. SUANFARMA Recent Developments/Updates

Table 90. Tecoland Corporation Corporation Information

Table 91. Tecoland Corporation Description and Business Overview

Table 92. Tecoland Corporation Bullous Pemphigoid Therapies Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Tecoland Corporation Bullous Pemphigoid Therapies Product

Table 94. Tecoland Corporation Recent Developments/Updates

Table 95. Century Pharmaceuticals Corporation Information

Table 96. Century Pharmaceuticals Description and Business Overview

Table 97. Century Pharmaceuticals Bullous Pemphigoid Therapies Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Century Pharmaceuticals Bullous Pemphigoid Therapies Product

Table 99. Century Pharmaceuticals Recent Developments/Updates

Table 100. Akari Therapeutics Corporation Information

Table 101. Akari Therapeutics Description and Business Overview

Table 102. Akari Therapeutics Bullous Pemphigoid Therapies Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Akari Therapeutics Bullous Pemphigoid Therapies Product

Table 104. Akari Therapeutics Recent Developments/Updates

Table 105. Immune Pharmaceuticals Corporation Information

Table 106. Immune Pharmaceuticals Description and Business Overview

Table 107. Immune Pharmaceuticals Bullous Pemphigoid Therapies Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Immune Pharmaceuticals Bullous Pemphigoid Therapies Product

Table 109. Immune Pharmaceuticals Recent Developments/Updates

Table 110. Innate Pharma Corporation Information

Table 111. Innate Pharma Description and Business Overview

Table 112. Innate Pharma Bullous Pemphigoid Therapies Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Innate Pharma Bullous Pemphigoid Therapies Product

Table 114. Innate Pharma Recent Developments/Updates

Table 115. AstraZeneca Corporation Information

Table 116. AstraZeneca Description and Business Overview

Table 117. AstraZeneca Bullous Pemphigoid Therapies Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. AstraZeneca Bullous Pemphigoid Therapies Product

Table 119. AstraZeneca Recent Developments/Updates

Table 120. Grifols Corporation Information

Table 121. Grifols Description and Business Overview

Table 122. Grifols Bullous Pemphigoid Therapies Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Grifols Bullous Pemphigoid Therapies Product

Table 124. Grifols Recent Developments/Updates

Table 125. Aptalis Corporation Information

Table 126. Aptalis Description and Business Overview

Table 127. Aptalis Bullous Pemphigoid Therapies Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Aptalis Bullous Pemphigoid Therapies Product

Table 129. Aptalis Recent Developments/Updates

Table 130. Medicis Pharmaceutical Corporation Corporation Information

Table 131. Medicis Pharmaceutical Corporation Description and Business Overview

Table 132. Medicis Pharmaceutical Corporation Bullous Pemphigoid Therapies Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. Medicis Pharmaceutical Corporation Bullous Pemphigoid Therapies Product

Table 134. Medicis Pharmaceutical Corporation Recent Developments/Updates

Table 135. Shaanxi Xiyue Pharmaceutical Corporation Information

Table 136. Shaanxi Xiyue Pharmaceutical Description and Business Overview

Table 137. Shaanxi Xiyue Pharmaceutical Bullous Pemphigoid Therapies Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 138. Shaanxi Xiyue Pharmaceutical Bullous Pemphigoid Therapies Product

Table 139. Shaanxi Xiyue Pharmaceutical Recent Developments/Updates

Table 140. Kunming Zhenhua Pharmaceutical Factory Corporation Information

Table 141. Kunming Zhenhua Pharmaceutical Factory Description and Business Overview

Table 142. Kunming Zhenhua Pharmaceutical Factory Bullous Pemphigoid Therapies Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 143. Kunming Zhenhua Pharmaceutical Factory Bullous Pemphigoid Therapies Product

Table 144. Kunming Zhenhua Pharmaceutical Factory Recent Developments/Updates

Table 145. Qinghai Pharmaceutical Factory Corporation Information

Table 146. Qinghai Pharmaceutical Factory Description and Business Overview

Table 147. Qinghai Pharmaceutical Factory Bullous Pemphigoid Therapies Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 148. Qinghai Pharmaceutical Factory Bullous Pemphigoid Therapies Product

Table 149. Qinghai Pharmaceutical Factory Recent Developments/Updates

Table 150. Key Raw Materials Lists

Table 151. Raw Materials Key Suppliers Lists

Table 152. Bullous Pemphigoid Therapies Distributors List

Table 153. Bullous Pemphigoid Therapies Customers List

Table 154. Bullous Pemphigoid Therapies Market Trends

Table 155. Bullous Pemphigoid Therapies Market Drivers

Table 156. Bullous Pemphigoid Therapies Market Challenges

Table 157. Bullous Pemphigoid Therapies Market Restraints

Table 158. Research Programs/Design for This Report

Table 159. Key Data Information from Secondary Sources

Table 160. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Bullous Pemphigoid Therapies

Figure 2. Global Bullous Pemphigoid Therapies Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Bullous Pemphigoid Therapies Market Share by Type in 2023 & 2030

Figure 4. Steroid Creams Product Picture

Figure 5. Immune Suppressants Product Picture

Figure 6. Antibiotics Product Picture

Figure 7. Global Bullous Pemphigoid Therapies Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Bullous Pemphigoid Therapies Market Share by Application in 2023 & 2030

Figure 9. Initial Phase

Figure 10. Active Treatment Phase

Figure 11. Reducing Phase

Figure 12. Maintenance Phase

Figure 13. Global Bullous Pemphigoid Therapies Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Bullous Pemphigoid Therapies Market Size (2019-2030) & (US$ Million)

Figure 15. Global Bullous Pemphigoid Therapies Sales (2019-2030) & (Units)

Figure 16. Global Bullous Pemphigoid Therapies Average Price (US$/Unit) & (2019-2030)

Figure 17. Bullous Pemphigoid Therapies Report Years Considered

Figure 18. Bullous Pemphigoid Therapies Sales Share by Manufacturers in 2023

Figure 19. Global Bullous Pemphigoid Therapies Revenue Share by Manufacturers in 2023

Figure 20. The Global 5 and 10 Largest Bullous Pemphigoid Therapies Players: Market Share by Revenue in 2023

Figure 21. Bullous Pemphigoid Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 22. Global Bullous Pemphigoid Therapies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America Bullous Pemphigoid Therapies Sales Market Share by Country (2019-2030)

Figure 24. North America Bullous Pemphigoid Therapies Revenue Market Share by Country (2019-2030)

Figure 25. United States Bullous Pemphigoid Therapies Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada Bullous Pemphigoid Therapies Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe Bullous Pemphigoid Therapies Sales Market Share by Country (2019-2030)

Figure 28. Europe Bullous Pemphigoid Therapies Revenue Market Share by Country (2019-2030)

Figure 29. Germany Bullous Pemphigoid Therapies Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France Bullous Pemphigoid Therapies Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. Bullous Pemphigoid Therapies Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy Bullous Pemphigoid Therapies Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia Bullous Pemphigoid Therapies Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Bullous Pemphigoid Therapies Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific Bullous Pemphigoid Therapies Revenue Market Share by Region (2019-2030)

Figure 36. China Bullous Pemphigoid Therapies Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan Bullous Pemphigoid Therapies Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea Bullous Pemphigoid Therapies Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India Bullous Pemphigoid Therapies Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia Bullous Pemphigoid Therapies Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. China Taiwan Bullous Pemphigoid Therapies Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Indonesia Bullous Pemphigoid Therapies Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Thailand Bullous Pemphigoid Therapies Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Malaysia Bullous Pemphigoid Therapies Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Latin America Bullous Pemphigoid Therapies Sales Market Share by Country (2019-2030)

Figure 46. Latin America Bullous Pemphigoid Therapies Revenue Market Share by Country (2019-2030)

Figure 47. Mexico Bullous Pemphigoid Therapies Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Brazil Bullous Pemphigoid Therapies Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Argentina Bullous Pemphigoid Therapies Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Middle East & Africa Bullous Pemphigoid Therapies Sales Market Share by Country (2019-2030)

Figure 51. Middle East & Africa Bullous Pemphigoid Therapies Revenue Market Share by Country (2019-2030)

Figure 52. Turkey Bullous Pemphigoid Therapies Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Bullous Pemphigoid Therapies Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. UAE Bullous Pemphigoid Therapies Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Global Sales Market Share of Bullous Pemphigoid Therapies by Type (2019-2030)

Figure 56. Global Revenue Market Share of Bullous Pemphigoid Therapies by Type (2019-2030)

Figure 57. Global Bullous Pemphigoid Therapies Price (US$/Unit) by Type (2019-2030)

Figure 58. Global Sales Market Share of Bullous Pemphigoid Therapies by Application (2019-2030)

Figure 59. Global Revenue Market Share of Bullous Pemphigoid Therapies by Application (2019-2030)

Figure 60. Global Bullous Pemphigoid Therapies Price (US$/Unit) by Application (2019-2030)

Figure 61. Bullous Pemphigoid Therapies Value Chain

Figure 62. Bullous Pemphigoid Therapies Production Process

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Distributors Profiles

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-9P7100

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Urticaria Drug Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-38Q7570

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Hyperpigmentation Disorder Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-9F12647

Fri Apr 26 00:00:00 UTC 2024

Add to Cart

Global Invisible Acne Patch Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-25M16883

Fri Apr 26 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Bullous Pemphigoid Therapies Market Research Report 2024

Published Date: March 2024

Report Code: QYRE-Auto-20Y14270

Global Bullous Pemphigoid Therapies Market Research Report 2024

FEATURED COMPANIES

Bullous Pemphigoid Therapies Market Size

Bullous Pemphigoid Therapies Market

Report Scope

Scope of Bullous Pemphigoid Therapies Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Bullous Pemphigoid Therapies Market report?

What are the Application segmentation covered in the Bullous Pemphigoid Therapies Market report?

What are the Type segmentation covered in the Bullous Pemphigoid Therapies Market report?

FEATURED COMPANIES

RELATED REPORTS